The impact of chip technology on cancer medicine

Annals of Oncology

Volumn 13, Issue SUPPL. 4, 2002, Pages 109-114

  Fey, M F ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; IMATINIB; MONOCLONAL ANTIBODY; ONCOPROTEIN; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER RESEARCH; CANCER SCREENING; CHRONIC MYELOID LEUKEMIA; DIAGNOSTIC PROCEDURE; DNA MICROARRAY; DNA SEQUENCE; GENE EXPRESSION PROFILING; GENOTYPE; HUMAN; HUMAN GENOME; IMMUNOHISTOCHEMISTRY; INFORMATION SYSTEM; MEDICAL GENETICS; MICROPROCESSOR; MOLECULAR GENETICS; ONCOGENE NEU; PRIORITY JOURNAL;

EID: 0036435897     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdf647     Document Type: Article

References (33)

1. Lindor NM, Greene MH and the Mayo Familial Cancer Program. The concise handbook of family cancer syndromes. J Natl Cancer Inst 1998; 90: 1039-1071.
2. Fey MF. Molecular biology of cancer. In Cavalli F, Hansen HH, Kaye SB (eds): Textbook of Medical Oncology, 2nd edition. London: Martin Dunitz 2000; 1-66.
3. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-532.
4. Wainscoat JS, Fey MF. Assessment of clonality in human tumors: a review. Cancer Res 1990; 50: 1355-1360.
5. International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921.
6. Venter JC, Adams MD, Myers EW et al. The sequence of the human genome. Science 2001; 291: 1304-1352.
7. Sidransky D. Nucleic acid-based methods for the detection of cancer. Science 1997; 278: 1054-1059.
8. Fey MF, Pilkington SP, Summers C, Wainscoat JS. Molecular diagnosis of haematological disorders using DNA from stored bone marrow slides. Br J Haematol 1987; 67: 489-492.
9. Steiner G, Schoenberg MP, Linn JF et al. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nature Med 1997; 3: 621-624.
10. Dong SM, Traverso G, Johnson C et al. Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst 2001; 93: 858-865.
11. Liloglou T, Maloney P, Xinarianos G et al. Cancer-specific genomic instability in bronchial lavage: a molecular tool for lung cancer detection. Cancer Res 2001; 61: 1624-1628.
12. Kononen J, Bubendorf L, Kallioniemi A et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Med 1998; 4: 844-847.
13. Bubendorf L, Kononen J, Koivisto P et al. Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridisation on tissue microarrays. Cancer Res 1999; 59: 803-806.
14. Emmert-Buck MR, Bonner RF, Smith PD et al. Laser capture micro-dissection. Science 1996; 274: 998-1001.
15. Rubin MA. Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate cancer. J Pathol 2001; 195: 80-86.
16. Hasse U, Tinguely M, Oppliger Leibundgut E et al. Clonal loss of heterozygosity in Hodgkin/Reed-Sternberg cells. J Natl Cancer Inst 1999; 91: 1581-1583.
17. Liotta L, Petrocoin E. Molecular profiling of human cancer. Nature Rev 2000; 1: 48-56.
18. Ramsay G. DNA chips: state-of-the-art. Nature Biotech 1998; 16: 40-44.
19. Aitman TJ. DNA microarrays in medical practice. Br Med J 2001; 323: 611-615.
20. Alizadeh AA, Ross DT, Perou CM, van de Rijn M. Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 2001; 195: 41-52.
21. Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-511.
22. Peron CM, Sorlie T, Eisen MB et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-752.
23. West M, Blanchette C, Dresman H et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA 2001; 98: 11462-11467.
24. Golub TR, Slonim DK, Tamayo P et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-537.
25. Rickman DS, Bobek MP, Misek DE et al. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 2001; 61: 6885-6891.
26. Su AI, Welsh JB, Sapinoso LM et al. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 2001; 61: 7388-7393.
27. Slamon DJ, Leyland-Jones B, Shak S et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344: 783-792.
28. Thor AD, Berry DA, Budman DR et al. erbB2, p53, and efficacy of adjuvant therapy in lymph node positive breast cancer. J Natl Cancer Inst 1998; 90: 1346-1360.
29. Druker BJ, Talpaz M, Resta D et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344: 1031-1037.
30. Scherf U, Ross DT, Waltham M et al. A gene expression database for the molecular pharmacology of cancer. Nature Genet 2000; 24: 236-244.
31. Kihara C, Tsunoda T, Tanaka T et al. Prediction of sensitivity of esophageal tumours to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res 2001; 61: 6474-6479.
32. Dua K, Williams TM, Beretta L. Translational control of the proteome: relevance to cancer. Proteomics 2001; 1: 1191-1199.
33. Martin DB, Nelson PS. From genomics to proteomics: techniques and applications in cancer research. Trends Cell Biol 2001; 11: S60-S65.